Portal Hypertension

Mission Statement

The Portal Study Group is dedicated to advancing the understanding, prevention, and treatment of liver diseases across North America. Our mission is to foster impactful research, innovative solutions, and collaborative efforts focused on improving liver health outcomes in the region's diverse and multiethnic populations. Through inclusivity, scientific rigor, and a commitment to health equity, we aim to enhance patient care and contribute to the global body of knowledge on liver disease.

Members of the North American Study Group